Advertisement
Lipella Pharma Soars 48% After FDA Oks IND For LP-310 For Oral Lichen Planus
(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced Friday that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for a multi-center, phase-2a, dose-escalation clinical trial.
The trial will assess the safety and efficacy of LP-310 in patients with symptomatic oral lichen planus (OLP), a highly morbid condition with no effective treatment.
In March 2023, Lipella created a five-member Scientific Advisory Board in Oral Health, made up of a group of highly regarded experts in oral medicine, to focus on the development of LP-310.
read more
Lipella Pharma Announces Top Line Results In Phase 2A Trial Of LP-10 For Hemorrhagic Cystitis
Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis, a rare but highly morbid disease for which there are currently no FDA approved treatments.
RTTNews
|
860 days ago
European Stocks Recover After Weak Start, Close Broadly Higher
European stocks closed broadly higher on Tuesday amid easing tariff worries, and expectations that Russia and Ukraine would soon begin ceasefire negotiations. The UK-EU trade agreement on Monday contributed as well to the positive mood in European markets.
RTTNews
|
3 minutes ago
TSX Extends Gains To 10th Straight Session, Hits New Record High
Canadian shares are up in positive territory Tuesday morning, extending gains to a tenth straight session, amid easing concerns about tariffs, and some brisk buying in gold stocks on safe-haven appeal following Moody's downgrading U.S. credit rating, citing debt concerns.
Investors are also digesting a report showing a drop in Canada's annual inflation rate.
RTTNews
|
1h 34min ago
Honda Cuts EV Sales, Investment Targets As It Shifts Focus
Honda Motor Co., Ltd. announced Tuesday that it is realigning automobile business strategy, with a cut in planned electric vehicle or EV sales ratio, and investment for automobile electrification due to the recent market slowdown. Meanwhile, Honda expects a minimal increase in investment related to Hybrid Electric Vehicle or HEV business.
RTTNews
|
2h 34min ago
Bay Street Likely To Open On Cautious Note; Inflation Data In Focus
The Canadian market is likely to see a cautious start Tuesday morning with investors reacting to the nation's consumer price inflation data.
RTTNews
|
5h 4min ago
U.S. Dollar Slides Amid U.S. Tariff Uncertainty
The U.S. dollar weakened against other major currencies in the European session on Tuesday, due to fiscal and economic concerns amid uncertainties about U.S. tariffs.
RTTNews
|
5h 30min ago
FTSE 100 Moderately Higher As Investors Focus On Earnings
U.K. stocks are up in positive territory on Tuesday, extending gains to a fourth straight session. The focus largely on corporate earnings updates, and the developments on the trade front.
RTTNews
|
6h 18min ago
Home Depot Q1 Profit Misses Market, But Sales Beat; Backs Outlook; Stock Up
Home Depot Inc. reported Tuesday weak first-quarter profit below market estimates, while sales grew from last year and beat the Street view with slightly higher comparable sales in the U.S. Further, the home improvement retailer maintained its fiscal 2025 guidance, expecting weak earnings, but higher sales and comparable sales. In the pre-market activity on the NYSE, Home Depot shares were gaining
RTTNews
|
6h 37min ago
